Relief of sleep apnoea after treatment of acromegaly: report of three cases and review of the literature.
Sleep apnoea syndrome (SAS) is common in acromegalic patients. Occasionally, the relief of apnoeas after treatment of the acromegaly has been documented. We report the cases of three patients with acromegaly and severe obstructive sleep apnoea, who demonstrated a manifest improvement (respiratory disturbance index (RDI) <20) after treatment with octreotide, indicating that this drug may be effective in this disturbance. In one case, SAS disappeared although the growth hormone level was not fully normalized. This raises the intriguing hypothesis that octreotide has an effect on respiratory control or on the upper airway, that is not directly related to its action on production of growth hormone.
Buyse
B
B
Division of pneumology, University Hospital Gasthuisberg, Catholic University Leuven, Belgium.
Michiels
E
E
Bouillon
R
R
Bobbaers
H
H
Demedts
M
M
D000172:Acromegaly / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D000368:Aged; D013006:Growth Hormone / Q000097:blood; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use; D017286:Polysomnography; D012123:Pulmonary Ventilation; D012891:Sleep Apnea Syndromes / Q000209:etiology / Q000503:physiopathology*
D006728:Hormones; D013006:Growth Hormone; D015282:Octreotide